Benefit versus Risk of Endomyocardial Biopsy for Heart Transplant Patients in the Contemporary Era

Vincenzo Cusi, Florin Vaida, Nicholas Wettersten, Nicholas Rodgers, Yuko Tada, Bryn Gerding, Barry Greenberg, Marcus Anthony Urey, Eric Adler, Paul J. Kim
doi: https://doi.org/10.1101/2023.05.19.23290196

Article Information

doi 
https://doi.org/10.1101/2023.05.19.23290196
History 
  • July 28, 2023.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Vincenzo Cusi1,
  2. Florin Vaida2,
  3. Nicholas Wettersten3,
  4. Nicholas Rodgers1,
  5. Yuko Tada1,
  6. Bryn Gerding1,
  7. Barry Greenberg1,
  8. Marcus Anthony Urey1,
  9. Eric Adler1 and
  10. Paul J. Kim1,*
  1. 1UC San Diego Health, San Diego, CA
  2. 2Department of Family Medicine and Public Health, UC San Diego, La Jolla, CA
  3. 3Cardiology Section, Veterans Affairs San Diego Healthcare System, San Diego, CA
  1. ↵*Address for Correspondence
    : Paul J. Kim, MD, Division of Cardiovascular Medicine, Department of Medicine UC San Diego Health, 9452 Medical Center Drive, MC 7411 La Jolla, CA 92037, Tel: 858-246-0638, Fax: 858-534-2000 email: pjk017{at}health.ucsd.edu
Back to top
Posted July 28, 2023.
Download PDF

Supplementary Material

Data/Code
Email
Benefit versus Risk of Endomyocardial Biopsy for Heart Transplant Patients in the Contemporary Era
Vincenzo Cusi, Florin Vaida, Nicholas Wettersten, Nicholas Rodgers, Yuko Tada, Bryn Gerding, Barry Greenberg, Marcus Anthony Urey, Eric Adler, Paul J. Kim
medRxiv 2023.05.19.23290196; doi: https://doi.org/10.1101/2023.05.19.23290196
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area